ANVS 8-K 2026-11-05

Annovis Bio, Inc. (ANVS) 8-K dated 2026-11-05 — accession 0001104659-26-123467.

Annovis Bio, Inc. (ANVS) is a biotechnology company listed on US.

Annovis Bio, Inc. filed a 8-K on 2026-11-05. Accession 0001104659-26-123467.

This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ANVS revenue for 2025-12-31 was $0. Net income was -$28.9M. ANVS currently screens at market cap $80.4M.

Not investment advice. The ANVS SEC hub lists recent forms. The stock page is the research view.